| Patient safety during procedural sedation using capnography monitoring: a systematic review and meta-analysis R Saunders, MMRF Struys, RF Pollock, M Mestek, JR Lightdale BMJ open 7 (6), e013402, 2017 | 120 | 2017 |
| Systematic review and meta-analysis of tacrolimus versus ciclosporin as primary immunosuppression after liver transplant G Muduma, R Saunders, I Odeyemi, RF Pollock PLoS One 11 (11), e0160421, 2016 | 89 | 2016 |
| Impact of stigma on people living with chronic hepatitis B J Smith-Palmer, K Cerri, U Sbarigia, EKH Chan, RF Pollock, WJ Valentine, ... Patient related outcome measures, 95-107, 2020 | 79 | 2020 |
| Computer modeling of diabetes and its transparency: a report on the eighth mount hood challenge AJ Palmer, L Si, M Tew, X Hua, MS Willis, C Asseburg, P McEwan, J Leal, ... Value in Health 21 (6), 724-731, 2018 | 78 | 2018 |
| Indirect methods of comparison of the safety of ferric derisomaltose, iron sucrose and ferric carboxymaltose in the treatment of iron deficiency anemia RF Pollock, P Biggar Expert Review of Hematology 13 (2), 187-195, 2020 | 45 | 2020 |
| Evaluating the cost‐effectiveness of laparoscopic adjustable gastric banding versus standard medical management in obese patients with type 2 diabetes in the UK RF Pollock, G Muduma, WJ Valentine Diabetes, Obesity and Metabolism 15 (2), 121-129, 2013 | 35 | 2013 |
| Long-acting insulin analogs: a review of “real-world” effectiveness in patients with type 2 diabetes R F Pollock, K M Erny-Albrecht, A Kalsekar, D Bruhn, W J Valentine Current diabetes reviews 7 (1), 61-74, 2011 | 35 | 2011 |
| Systematic review and network meta-analyses of third-line treatments for metastatic colorectal cancer T Walter, NS Hawkins, RF Pollock, F Colaone, S Shergill, PJ Ross Journal of Cancer Research and Clinical Oncology 146, 2575-2587, 2020 | 34 | 2020 |
| Evaluation of the cost-utility of insulin degludec vs insulin glargine in Sweden Å Ericsson, RF Pollock, B Hunt, WJ Valentine Journal of medical economics 16 (12), 1442-1452, 2013 | 33 | 2013 |
| Management of patients with type 2 diabetes with once-weekly semaglutide versus dulaglutide, exenatide ER, liraglutide and lixisenatide: a cost-effectiveness analysis in the … P Gæde, P Johansen, CK Tikkanen, RF Pollock, B Hunt, SJP Malkin Diabetes Therapy 10, 1297-1317, 2019 | 31 | 2019 |
| Review of the clinical and economic burden of antibody-mediated rejection in renal transplant recipients G Muduma, I Odeyemi, J Smith-Palmer, RF Pollock Advances in therapy 33, 345-356, 2016 | 31 | 2016 |
| Evaluating the cost-effectiveness of self-monitoring of blood glucose in type 2 diabetes patients on oral anti-diabetic agents R Pollock, W Valentine, G Goodall, M Brändle Swiss medical weekly 140 (4344), w13103-w13103, 2010 | 30 | 2010 |
| A systematic literature review and indirect comparison of iron isomaltoside and ferric carboxymaltose in iron deficiency anemia after failure or intolerance of oral iron treatment RF Pollock, G Muduma Expert Review of Hematology 12 (2), 129-136, 2019 | 26 | 2019 |
| Evaluating the cost‐effectiveness of reduced mild hypoglycaemia in subjects with type 1 diabetes treated with insulin detemir or NPH insulin in Denmark, Sweden, Finland and the … WJ Valentine, J Jendle, M Saraheimo, B Thorsteinsson, RF Pollock, ... Diabetic medicine 29 (3), 303-312, 2012 | 26 | 2012 |
| The cost effectiveness of rapid-acting insulin aspart compared with human insulin in type 2 diabetes patients: an analysis from the Japanese third-party payer perspective RF Pollock, WJ Valentine, T Pilgaard, H Nishimura Journal of medical economics 14 (1), 36-46, 2011 | 25 | 2011 |
| A short-term cost-utility analysis of insulin degludec versus insulin glargine U100 in patients with type 1 or type 2 diabetes in Denmark RF Pollock, CK Tikkanen Journal of Medical Economics 20 (3), 213-220, 2017 | 24 | 2017 |
| A budget impact analysis of parenteral iron treatments for iron deficiency anemia in the UK: reduced resource utilization with iron isomaltoside 1000 RF Pollock, G Muduma ClinicoEconomics and Outcomes Research, 475-483, 2017 | 22 | 2017 |
| Systematic review of the cost-effectiveness of biphasic insulin aspart 30 in type 2 diabetes WJ Valentine, RF Pollock, J Plun-Favreau, J White Current Medical Research and Opinion 26 (6), 1399-1412, 2010 | 22 | 2010 |
| Intermediate and high-risk non-muscle-invasive bladder cancer: an overview of epidemiology, burden, and unmet needs K Grabe-Heyne, C Henne, P Mariappan, G Geiges, J Pöhlmann, ... Frontiers in Oncology 13, 1170124, 2023 | 20 | 2023 |
| A patient-level cost-effectiveness analysis of iron isomaltoside versus ferric carboxymaltose for the treatment of iron deficiency anemia in the United Kingdom RF Pollock, G Muduma Journal of Medical Economics 23 (7), 751-759, 2020 | 20 | 2020 |